我们如何删除错误的青素过敏标签?
1Public Health Directorate, NHS Lanarkshire, Kirklands, Fallside Road, Bothwell, G71 8BB, UK. albert.yeung@lanarkshire.scot.nhs.uk.
Evidence-based dentistry
|January 9, 2025
概括
用于改善治疗的青素过敏再评估 (PARTI) 工具是通过使用患者和医疗保健工作者反来改进的. 这种最终完成的工具旨在改善牙科机构对青素过敏的沟通.
科学领域:
- 牙科医学 牙科医学
- 临床信息学是一种临床信息学.
- 患者安全 患者安全
背景情况:
- 准确的青素过敏标签在牙科实践中至关重要,以防止不必要地避免青素抗生素.
- 在牙科中关于青素过敏的现有通信方法可能是不理想的.
- 青素过敏再评估以改善治疗 (PARTI) 工具是为了帮助这一过程而开发的.
研究的目的:
- 评估PARTI工具在牙科实践中支持适当的青素过敏标签的实用性.
- 收集患者和医疗保健专业人员的反,以完善PARTI工具的最佳使用.
主要方法:
- 采用了并行混合方法研究设计.
- 专注组与患有已记录的青素过敏的患者以及针对医疗保健工作人员的有针对性的问卷进行了调查.
- 来自焦点组和问卷调查的定性数据使用修改的基础理论方法进行了分析.
主要成果:
- 15名患者和50名医疗保健工作人员对PARTI工具提供了反.
- 参与者提出了建设性的改进建议,许多医疗保健工作者强调了青素过敏测试部分的重要性.
- 反成功地纳入了PARTI工具的最终版本.
结论:
- 患者和医疗保健工作人员的意见对完成PARTI工具起了重要作用.
- 精细的PARTI工具旨在加强牙医和患者之间关于青素过敏的沟通.
- 该工具支持在牙科环境中进行适当的青素过敏评估和标签.
相关概念视频
Allergic Reactions
27.2K
Overview
27.2K
Allergic Drug Reactions
809
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
809
Pharmacovigilance
771
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
771


